ICAM1 and acute respiratory distress syndrome: S. Jiang [78] designed a ternary nanoparticle (ICAM-NLC/Pro/Ang) containing anti-cellular ICAM-1, which could be targeted for the treatment of ALI and significantly reduced TNF-α and IL-6 levels in the lungs of mice.